EP0487591 - ANTICOAGULANT PROTEIN [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.10.1994 Database last updated on 30.10.2024 | Most recent event Tooltip | 06.10.1994 | No opposition filed within time limit | published on 23.11.1994 [1994/47] | Applicant(s) | For all designated states NOVO NORDISK A/S Novo Allé 2880 Bagsværd / DK | [N/P] |
Former [1992/23] | For all designated states NOVO NORDISK A/S Novo Allé DK-2880 Bagsvaerd / DK | Inventor(s) | 01 /
RASMUSSEN, Jesper, Skou Linde Allé 50, 2. t.h. DK-2720 Vanloese / DK | 02 /
NORDFANG, Ole, Juul Selskovvej 6 DK-3400 Hilleroed / DK | [1992/23] | Representative(s) | Pettersson, Poul Eisten c/o Novo Nordisk A/S Patent Department Novo Allé 2880 Bagsvaerd / DK | [N/P] |
Former [1992/23] | Pettersson, Poul Eisten c/o Novo Nordisk A/S Patent Department Novo Allé DK-2880 Bagsvaerd / DK | Application number, filing date | 90912756.5 | 17.08.1990 | [1992/23] | WO1990DK00212 | Priority number, date | DK19890004080 | 18.08.1989 Original published format: DK 408089 | [1992/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9102753 | Date: | 07.03.1991 | Language: | EN | [1991/06] | Type: | A1 Application with search report | No.: | EP0487591 | Date: | 03.06.1992 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.03.1991 takes the place of the publication of the European patent application. | [1992/23] | Type: | B1 Patent specification | No.: | EP0487591 | Date: | 01.12.1993 | Language: | EN | [1993/48] | Search report(s) | International search report - published on: | SE | 07.03.1991 | Classification | IPC: | C07K13/00, C12N15/15, A61K37/64 | [1992/23] | CPC: |
C07K14/8114 (EP,US);
A61P35/00 (EP);
A61P7/02 (EP);
A61K38/00 (EP,US)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, IT, LI, LU, NL, SE [1992/23] | Title | German: | ANTIKOAGULIERENDES PROTEIN | [1992/23] | English: | ANTICOAGULANT PROTEIN | [1992/23] | French: | PROTEINE ANTICOAGULANTE | [1992/23] | Entry into regional phase | 21.01.1992 | National basic fee paid | 21.01.1992 | Designation fee(s) paid | 21.01.1992 | Examination fee paid | Examination procedure | 04.02.1991 | Request for preliminary examination filed International Preliminary Examining Authority: DE | 21.01.1992 | Examination requested [1992/23] | 22.03.1993 | Despatch of communication of intention to grant (Approval: Yes) | 25.05.1993 | Communication of intention to grant the patent | 19.08.1993 | Fee for grant paid | 19.08.1993 | Fee for publishing/printing paid | Opposition(s) | 02.09.1994 | No opposition filed within time limit [1994/47] | Fees paid | Renewal fee | 13.06.1992 | Renewal fee patent year 03 | 22.05.1993 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]EP0300988 (UNIV WASHINGTON [US]); | [Y]EP0318451 (MONSANTO CO [US], et al) | [X] - Nature, Vol. 338, 1989 J. GIRARD et al.: "Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor", see especially p. 518 col. 2 lines 11-12, p. 520 col 1 lines 1-8. | [A] - Thrombosis research, Vol. 48, 1987 B.J. WARN-CRAMER et al.: "Partial Purification and characterization of extrinsic", see page 11 - page 22. | [A] - Proc. Natl. Acad. Sci., Vol. 84, 1987 GEORGE J. BROZE, Jr. et al.: "Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells", see page 1886 - page 1890. |